Ana Janic is Associate Professor and Principal Investigator at Department of Medicine and Life Sciences at Pompeu Fabra University (MELIS-UPF).
She studied Molecular Biology and Physiology at the University of Belgrade and completed her master research studies at European Molecular Biology Laboratories (EMBL) in Hamburg, Germany. She obtained PhD in Biomedicine at Institute for Research in Biomedicine (IRB- Barcelona) in 2011. During her PhD, she studied the molecular basis of cancer using Drosophila as a model organism.
After completing PhD, she moved to Andreas Strasser laboratory at Walter and Eliza Hall Institute, Australia. Her studies helped to uncover how p53 prevents the development of cancer, including identifying DNA repair as an essential process for p53-mediated tumor suppression. In 2018 she established her independent research group at DCEXS-UPF and her research program is dedicated to understanding the complex p53 tumour suppression transcriptional network in different tissues and in the context of distinct oncogenic drivers.